⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL475083 | 0.97 | — | — | |
| SCHEMBL15068126 | 0.93 | — | — | |
| Ammonia Solution, Strong SCHEMBL8428644 | 0.93 | LMNA (0.60) | — | |
| Iodide SCHEMBL11881090 | 0.90 | LMNA (0.56) | — | |
| Levulinic Acid SCHEMBL18740348 | 0.83 | LMNA (0.74) | — | |
| Succinic Acid SCHEMBL27576268 | 0.82 | LMNA (0.75) | — | |
| Succinic Acid SCHEMBL27576266 | 0.82 | LMNA (0.75) | — | |
| Succinic Acid SCHEMBL5017517 | 0.82 | — | — | |
| Succinic Acid SCHEMBL2727146 | 0.82 | LMNA (0.90) | — | |
| SCHEMBL43375 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1658273-A1 | COMPOUNDS, METHODS AND FORMULATIONS FOR THE ORAL DELIVERY OF A GLUCAGON LIKE PEPTIDE (GLP)-1 COMPOUND OR AN MELANOCORTIN 4 RECEPTOR (MC4) AGONIST PEPTIDE | ELI LILLY AND COMPANY (US) | 2006-05-24 | — | — | EP | disclosed |
| WO-2005019184-A1 | COMPOUNDS, METHODS AND FORMULATIONS FOR THE ORAL DELIVERY OF A GLUCAGON LIKE PEPTIDE (GLP)-1 COMPOUND OR AN MELANOCORTIN 4 RECEPTOR (MC4) AGONIST PEPTIDE | ELI LILLY AND COMPANY (US) | 2005-03-03 | — | — | WO | disclosed |